2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference


To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Esposito E et al. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. 2012 Eur J Pharm Biopharm pmid:22061262
López CA et al. Amylose folding under the influence of lipids. 2012 Carbohydr. Res. pmid:23128420
Saadeh M et al. Reactive oxygen species stimulate insulin secretion in rat pancreatic islets: studies using mono-oleoyl-glycerol. 2012 PLoS ONE pmid:22272304
Pepe D et al. Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. 2012 Int J Pharm pmid:22692080
Panapisal V et al. Formulation of microemulsion systems for dermal delivery of silymarin. 2012 AAPS PharmSciTech pmid:22350738
Chong JY et al. High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. 2012 Langmuir pmid:22630595
Kubicek J et al. Controlled in meso phase crystallization--a method for the structural investigation of membrane proteins. 2012 PLoS ONE pmid:22536388
Moebus K et al. Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces. 2012 J Control Release pmid:21963767
Onoue S et al. Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. 2012 Eur J Pharm Biopharm pmid:22008148
Cohen-Avrahami M et al. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac. 2012 J Control Release pmid:22306174
Lopes I et al. Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. 2012 Ecotoxicology pmid:22314390
Garti N et al. Lipolysis and structure controlled drug release from reversed hexagonal mesophase. 2012 Colloids Surf B Biointerfaces pmid:22341515
Issa JP et al. Biological evaluation of the bone healing process after application of two potentially osteogenic proteins: an animal experimental model. 2012 Gerodontology pmid:22970792
Labahn J et al. Vapor diffusion-controlled meso crystallization of membrane proteins. 2012 Methods Mol. Biol. pmid:22976020
Jain V et al. Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy. 2012 Biomaterials pmid:22809646
Angelov B et al. Protein-containing PEGylated cubosomic particles: freeze-fracture electron microscopy and synchrotron radiation circular dichroism study. 2012 J Phys Chem B pmid:22720820
Zhen G et al. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro. 2012 Mol. Pharm. pmid:22794355
Kundu P et al. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy. 2012 Acta Biomater pmid:22484149
Yaghmur A et al. Self-assembled nanostructures of fully hydrated monoelaidin-elaidic acid and monoelaidin-oleic acid systems. 2012 Langmuir pmid:22690845
Kwon TK and Kim JC Monoolein cubic phase containing acidic proteinoid: pH-dependent release. 2011 Drug Dev Ind Pharm pmid:20528616
Pandit AA and Dash AK Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. 2011 Nanomedicine (Lond) pmid:22091968
Hansen KB et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. 2011 J. Clin. Endocrinol. Metab. pmid:21778222
Silva JP et al. DODAB:monoolein-based lipoplexes as non-viral vectors for transfection of mammalian cells. 2011 Biochim. Biophys. Acta pmid:21787746
Kulkarni CV Nanostructural studies on monoelaidin-water systems at low temperatures. 2011 Langmuir pmid:21846133
Bitan-Cherbakovsky L et al. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions. 2011 J Phys Chem B pmid:21902258
Joseph JS et al. Characterization of lipid matrices for membrane protein crystallization by high-throughput small angle X-ray scattering. 2011 Methods pmid:21903166
Wallace E et al. Monoolein lipid phases as incorporation and enrichment materials for membrane protein crystallization. 2011 PLoS ONE pmid:21909395
Phan S et al. Evaluating the link between self-assembled mesophase structure and drug release. 2011 Int J Pharm pmid:21963475
Falkman P et al. Lyotropic lipid phases confined in cylindrical pores: structure and permeability. 2011 J Phys Chem B pmid:22007791
Lian R et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. 2011 AAPS PharmSciTech pmid:21948306
Zhai J et al. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles. 2011 Langmuir pmid:22026367
Montenegro L et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. 2011 Drug Dev Ind Pharm pmid:21204752
Yaghmur A et al. The role of calcium in membrane condensation and spontaneous curvature variations in model lipidic systems. 2011 Phys Chem Chem Phys pmid:21049109
Rossetti FC et al. Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: evaluation of drug and pharmaceutical additives influence on the internal structure. 2011 J Pharm Sci pmid:21337546
Libster D et al. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications. 2011 J Colloid Interface Sci pmid:21315366
Alam MM et al. Kinetics of low pH-induced lamellar to bicontinuous cubic phase transition in dioleoylphosphatidylserine∕monoolein. 2011 J Chem Phys pmid:21495771
Nguyen TH et al. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. 2011 J Control Release pmid:21497623
Liu Y et al. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. 2011 Int J Pharm pmid:21540088
Trickler WJ et al. Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel. 2011 Nanomedicine (Lond) pmid:21542683
Dong YD et al. Adsorption of nonlamellar nanostructured liquid-crystalline particles to biorelevant surfaces for improved delivery of bioactive compounds. 2011 ACS Appl Mater Interfaces pmid:21506614
Ghosh S et al. Comparison of Pickering and network stabilization in water-in-oil emulsions. 2011 Langmuir pmid:21528852
Jin J et al. Production of diacylglycerols from glycerol monooleate and ethyl oleate through free and immobilized lipase-catalyzed consecutive reactions. 2011 N Biotechnol pmid:20951847
Tilley A et al. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol. 2011 Phys Chem Chem Phys pmid:21240427
Rizwan SB et al. Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. 2011 Eur J Pharm Biopharm pmid:21237267
Kulkarni CV et al. Monoolein: a magic lipid? 2011 Phys Chem Chem Phys pmid:21183976
Achrai B et al. Solubilization of gabapentin into HII mesophases. 2011 J Phys Chem B pmid:21182317
Kwon TK and Kim JC Complex coacervation-controlled release from monoolein cubic phase containing silk fibroin and alginate. 2011 Biomacromolecules pmid:21190340
Angelov B et al. SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers. 2011 Phys Chem Chem Phys pmid:21079857
Yuan L and Zheng YF A microdevice for the mixing of a highly viscous biosample with water/membrane protein solution using microchannel and centrifugation. 2011 J Lab Autom pmid:21609687
Amar-Zrihen N et al. Food volatile compounds facilitating HII mesophase formation: solubilization and stability. 2011 J. Agric. Food Chem. pmid:21495722